image_alt_text
8

Andrew Wang, MD

AIMBE College of Fellows Class of 2019
For outstanding contributions in translating advances from nanomedicine and drug delivery research to improving cancer management and treatment.

Dr. Andrew Wang Inducted into Medical and Biological Engineering Elite

Via AIMBE | March 28, 2019

WASHINGTON, D.C.—The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Andrew Wang, MD, Associate Professor and Director of Clinical and Translational Research, Department of Radiation Oncology, University of North Carolina-Chapel Hill, to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Dr. Wang was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions in translating advances from nanomedicine and drug delivery research to improving cancer management and treatment.”